Found 5 matching trials
Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine PHASE3 Primary Objective:
To demonstrate non-inferiority of SAR341402 versus Novo...
Show More Location
Investigational Site Number 8400040
Learn More & Join Trial
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine PHASE3 Primary Objective:
To demonstrate similarity in pharmacokinetics (PK) of S...
Show More Location
Investigational Site Number 8400014
Learn More & Join Trial
Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus PHASE1 Primary Objectives:
* To demonstrate similarity in exposure of SAR341402 M...
Show More Location
Investigational Site Number 2760001
Learn More & Join Trial
A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus PHASE1 Primary Objective:
To compare exposure and activity of SAR341402 to NovoRa...
Show More Location
Investigational Site 276001
Learn More & Join Trial
Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients PHASE1 Primary Objective:
\- To assess the safety of SAR341402 and NovoLog® when ...
Show More Location
Investigational Site Number 8400001
Learn More & Join Trial